| The 6-hydroxydopamine model of Parkinson’s disease N Simola, M Morelli, AR Carta Neurotoxicity research 11, 151-167, 2007 | 516 | 2007 |
| Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 491 | 2015 |
| Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms R Moratalla, A Khairnar, N Simola, N Granado, JR García-Montes, ... Progress in neurobiology 155, 149-170, 2017 | 246 | 2017 |
| Gut microbiota and metabolome alterations associated with Parkinson’s disease S Vascellari, V Palmas, M Melis, S Pisanu, R Cusano, P Uva, D Perra, ... Msystems 5 (5), 10.1128/msystems. 00561-20, 2020 | 154 | 2020 |
| Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward N Simola, S Fenu, G Costa, A Pinna, A Plumitallo, M Morelli Neuropharmacology 63 (2), 224-234, 2012 | 125 | 2012 |
| New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists A Pinna, J Wardas, N Simola, M Morelli Life sciences 77 (26), 3259-3267, 2005 | 122 | 2005 |
| Dyskinesia in Parkinson's disease: mechanisms and current non‐pharmacological interventions R Heumann, R Moratalla, MT Herrero, K Chakrabarty, R Drucker‐Colín, ... Journal of Neurochemistry 130 (4), 472-489, 2014 | 117 | 2014 |
| Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease N Simola, S Granon Neuropharmacology 159, 107420, 2019 | 112 | 2019 |
| Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats E Tronci, N Simola, F Borsini, N Schintu, L Frau, P Carminati, M Morelli European journal of pharmacology 566 (1-3), 94-102, 2007 | 103 | 2007 |
| Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson’s Disease S Kasture, S Pontis, A Pinna, N Schintu, L Spina, R Longoni, N Simola, ... Neurotoxicity research 15, 111-122, 2009 | 102 | 2009 |
| Anxiolytic-like Effects of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis F Da Settimo, F Simorini, S Taliani, C La Motta, AM Marini, S Salerno, ... Journal of medicinal chemistry 51 (18), 5798-5806, 2008 | 102 | 2008 |
| l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies A Pinna, J Bonaventura, D Farré, M Sánchez, N Simola, J Mallol, C Lluís, ... Experimental neurology 253, 180-191, 2014 | 98 | 2014 |
| Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions N Simola, S Fenu, PG Baraldi, MA Tabrizi, M Morelli Experimental neurology 189 (1), 182-188, 2004 | 96 | 2004 |
| Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease N Simola Current Neuropharmacology 13 (2), 164-179, 2015 | 91 | 2015 |
| Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins M Herrera-Marschitz, P Morales, L Leyton, D Bustamante, V Klawitter, ... Neurotoxicity research 19, 603-627, 2011 | 83 | 2011 |
| Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions N Simola, M Morelli, A Pinna Current pharmaceutical design 14 (15), 1475-1489, 2008 | 79 | 2008 |
| Strain dependence of adolescent C annabis influence on heroin reward and mesolimbic dopamine transmission in adult L ewis and F ischer 344 rats C Cadoni, N Simola, E Espa, S Fenu, G Di Chiara Addiction biology 20 (1), 132-142, 2015 | 73 | 2015 |
| Perinatal asphyxia: CNS development and deficits with delayed onset M Herrera-Marschitz, T Neira-Pena, E Rojas-Mancilla, P Espina-Marchant, ... Frontiers in neuroscience 8, 47, 2014 | 71 | 2014 |
| Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the … N Simola, L Frau, A Plumitallo, M Morelli International Journal of Neuropsychopharmacology 17 (3), 429-441, 2014 | 68 | 2014 |
| Striatal neuroprotection with methylene blue JC Rojas, N Simola, BA Kermath, JR Kane, T Schallert, F Gonzalez-Lima Neuroscience 163 (3), 877-889, 2009 | 64 | 2009 |
Giulia CostaUniversità degli Studi di CagliariVerified email at unica.it
